A new Risk Evaluation and Mitigation Strategy (REMS) will aim to reduce the misuse of long-acting opioid pain meds (OxyContin, etc)

June 2011

A new Risk Evaluation and Mitigation Strategy (REMS) will aim to reduce the misuse of long-acting opioid pain meds (OxyContin, etc).

Unintentional deaths due to opioids have quadrupled in 8 years...and treatment for opioid abuse has increased five-fold in 10 years.

Now FDA will require manufacturers to come up with a REMS plan by mid-August...with the changes rolled out by early 2012.

Practical advice for a better career, with unlimited access to CE

Pharmacy Technician's Letter Canada includes:

  • 12 issues every year, with brief articles about new meds and hot topics
  • 120+ CE courses, including the popular CE-in-the-Letter
  • Helpful, in-depth Technician Tutorials
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get a quote